000 01159 a2200325 4500
005 20250515002711.0
264 0 _c20060404
008 200604s 0 0 eng d
022 _a0006-4971
024 7 _a10.1182/blood-2005-02-0819
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMontserrat, Emili
245 0 0 _aHow I treat refractory CLL.
_h[electronic resource]
260 _bBlood
_cFeb 2006
300 _a1276-83 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aHumans
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xdiagnosis
700 1 _aMoreno, Carol
700 1 _aEsteve, Jordi
700 1 _aUrbano-Ispizua, Alvaro
700 1 _aGiné, Eva
700 1 _aBosch, Francesc
773 0 _tBlood
_gvol. 107
_gno. 4
_gp. 1276-83
856 4 0 _uhttps://doi.org/10.1182/blood-2005-02-0819
_zAvailable from publisher's website
999 _c15834240
_d15834240